Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development. (Q50234451)
Jump to navigation
Jump to search
scientific article published on 2 February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development. |
scientific article published on 2 February 2010 |
Statements
1 reference
Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development. (English)
1 reference
Mike Ufer
1 reference
2 February 2010
1 reference
103
1 reference
3
1 reference
572-585
1 reference
Identifiers
1 reference